Rhode Island SB 2122: AN ACT RELATING TO BUSINESSES AND PROFESSIONS -- PRESCRIPTION DRUG SALES -- REPRESENTATIVE DISCLOSURE ACT (Requires prescription drug manufacturers to file a detailed, updated list of each pharmaceutical sales representative and to pay an annual fee for each name listed with the department of business regulation.)

Status: 02/25/2020 Committee recommended measure be held for further study (as of 2020-02-25)

State: Rhode Island · Session: 2020 · Bill: SB 2122

Subjects: Business & Professions, Civil Procedure, Prescription drugs

Sponsors: Miller

View Rhode Island SB 2122 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.